Susan Garfield, DrPH, is Vice President, Bridgehead USA. She is a market access, reimbursement and economics strategist, with an expertise in demand creation and advocacy. For over twelve years, her professional career has focused on innovations in healthcare, the economics of practice change, and the role of reimbursement and policy to the adoption of new technologies. Dr Garfield's work has included economic modelling, coding analyses and applications, payer coverage campaigns, market strategies for innovative technologies, health policy development, government relations, and creating partnerships between industry and advocacy groups.
Prior to joining Bridgehead, Dr. Garfield was the Director, Global Reimbursement, Policy and Economic Strategy at QIAGEN Corporation (formally Digene Corporation). In this role, she planned and executed a reimbursement strategy that resulted in near universal coverage for the company's leading cancer diagnostic product. In addition, she directed global economic and pricing analyses for the company's clinical diagnostic portfolio. Before QIAGEN, Dr Garfield was a Director at Boston Healthcare Consulting. During her tenure there, Dr Garfield worked with biotechnology, medical device, pharmaceutical, and diagnostic firms on market access strategy and execution. In this role she translated primary research with over 2000 clinicians, payers, government decision-makers and patients into actionable programs for clients.
Dr Garfield received her Bachelor’s of Art in English and Women's Studies from the University of Pennsylvania, a Master's of Science in Population and Development from the London School of Economics, and a Master's of Science in Health Policy and Management from Harvard University, School of Public Health. She received her Doctorate of Public Health at Boston University with a focus on reimbursement policy and technology diffusion.
